Designing multi-targeted therapeutics for the treatment of Alzheimer's disease

I Erdogan Orhan, F Sezer Senol - Current topics in medicinal …, 2016 - ingentaconnect.com
Due to multi-faceted pathology of AD; no drug can seize the progress of the disease,
whereas only the symptomatic treatment is available at the moment. Several drug classes to …
被引用次数：23 相关文章

Designing Multi-Targeted Therapeutics for the Treatment of Alzheimer's Disease.

IE Orhan, FS Senol - Current Topics in Medicinal Chemistry, 2016 - europepmc.org
Due to multi-faceted pathology of AD; no drug can seize the progress of the disease,
whereas only the symptomatic treatment is available at the moment. Several drug classes to …

[引用][C] Designing Multi-Targeted Therapeutics for the Treatment of Alzheimer's Disease

IE Orhan, FS Senol, S Tejada… - Current Topics in …, 1889 - ingentaconnect.com
Graphical Abstracts Page 1 i Current Topics in Medicinal Chemistry, 2016, Vol. 16, No. 17
Graphical Abstracts Graphical Abstracts Current Topics in Medicinal Chemistry; Vol. 16, 2016 …

Designing Multi-Targeted Therapeutics for the Treatment of Alzheimer's Disease

İ ERDOĞAN ORHAN… - CURRENT TOPICS IN …, 2016 - avesis.gazi.edu.tr
Due to multi-faceted pathology of AD; no drug can seize the progress of the disease,
whereas only the symptomatic treatment is available at the moment. Several drug classes to …

Designing Multi-Targeted Therapeutics for the Treatment of Alzheimer's Disease

IE Orhan, FS Senol - Current topics in medicinal chemistry, 2016 - pubmed.ncbi.nlm.nih.gov
Due to multi-faceted pathology of AD; no drug can seize the progress of the disease,
whereas only the symptomatic treatment is available at the moment. Several drug classes to …